Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol for pediatric MRI sedation
ChiCTR2400087949Phase 4Recruiting
- Sponsor
- Maternal and Child Health Hospital of Hubei Province
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam in None (2 arms), sponsored by Maternal and Child Health Hospital of Hubei Province. Primary endpoints: Heart rate and SpO2. Started Aug 2024; status: recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2400087949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400087949.